Literature DB >> 18156037

Genital herpes in Africa: time to rethink treatment.

Nigel O'Farrell1, Prashini Moodley, A Wim Sturm.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 18156037     DOI: 10.1016/S0140-6736(07)61910-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior.

Authors:  Haile Selassie Okuku; Eduard J Sanders; Joyce Nyiro; Caroline Ngetsa; Eric Ohuma; R Scott McClelland; Matthew A Price; Susan M Graham
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

2.  Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda.

Authors:  Aaron A R Tobian; Blake Charvat; Victor Ssempijja; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Boaz Iga; Oliver Laeyendecker; Melissa Riedesel; Amy Oliver; Michael Z Chen; Steven J Reynolds; Maria J Wawer; Ronald H Gray; Thomas C Quinn
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

3.  CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.

Authors:  Manoj Thapa; Daniel J J Carr
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

Review 4.  Light microscopy, culture, molecular, and serologic methods for detection of herpes simplex virus.

Authors:  Neil W Anderson; Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.